Lumos Diagnostics specializes in rapid, cost-effective and proprietary point-of-care (POC) diagnostic test technologies for healthcare professionals. Lumos’ POC tests include FebriDx® and CoviDx™. The FebriDx 10 minute viral and bacterial immune response test has received regulatory approval in Europe, Canada and Australia and is under FDA review in the United States. CoviDx is a SARS-CoV-2 rapid antigen test that is CE marked and also under U.S. FDA review.
Learn More, www.lumosdiagnostics.com